2020
Bylsma LC , Dean R, Lowe K, Sangare L, Alexander D, Fryzek J. The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.
View Abstract
Publication: Abstracts and Presentations
Broome CM, Cunningham JM, Mullins M, Jiang X , Bylsma LC , Fryzek JP, Rosenthal A. 2020. Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis. Res Prac Thromb Haemostas 4(4):628-635; doi: 10.1002/rth2.12333 .
View Abstract
Publication: Manuscripts
Patel P, Jiang X , Nicholson G, Frankenfeld C , Iglesias-Rodriguez, Fryzek J, Su J. Medically attended anxiety or depression is increased among newly diagnosed patients with cold agglutinin disease (CAD). Virtual presentation to American Society of Hematology, 2020.
Publication: Abstracts and Presentations
Frankenfeld CL , Menon N, Leslie TF. 2020. Racial disparities in colorectal cancer time-to-treatment and survival time for colorectal tumors and diagnosing hospital cancer-related diagnostic and treatment capabilities. Cancer Epidemiol 65:101684, https://doi.org/10.1016/j.canep.2020.101684 .
View Abstract
Publication: Manuscripts
Menon N, Leslie TF, Frankenfeld CL . 2020. Cancer-related diagnostic and treatment capabilities of hospitals in the context of racial residential segregation. Public Health 182(May):95–101; doi: 10.1016/j.puhe.2020.02.004 .
View Abstract
Publication: Manuscripts
Nordyke RJ , Nicholson G, Gage SM, Lithgow T, Himmelfarb J, Rivara MB, Hays RD, Woo K, Peipert JD. 2020. Vascular access-specific health-related quality of life impacts among hemodialysis patients: Qualitative development of the hemodialysis access-related quality of life (HARQ) instrument. BMC Nephrol 14;21(1):16; doi: 10.1186/s12882-020-1683-5 . PMID: 31937249.
View Abstract
Publication: Manuscripts
2019
Hooda N , Quinn E, DeAngelis C, Pasetka M, McFarlane T. 2019. Delayed CINV in FOLFOX chemotherapy: A retrospective chart review comparing two Ontario hospitals. J Oncol Pharmacy Prac (abstract 22), doi:10.1177/1078155219834495.
View Abstract
Publication: Manuscripts
Malone DC, Dean R, Arjunji R, Jensen IS , Cyr PL , Miller B, Maru B, et al. 2019. Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients. J Mark Access Health Pol 7(1):1601484; doi: 10.1080/20016689.2019 .
View Abstract
Publication: Manuscripts
Fryzek J, Bylsma LC, Nordyke RJ , Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.